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Background: Microscopy and rapid diagnostic tests (RDTs) are common tools for diagnosing malaria, but are
deficient in detecting low Plasmodium parasitaemia. A novel molecular diagnostic tool (nPCR-HRM) that combines
the sensitivity and specificity of nested PCR (nPCR) and direct PCR-high resolution melting analysis (dPCR-HRM) was
developed. To evaluate patterns of anti-malarial drug administration when no parasites are detected, nPCR-HRM
was employed to screen blood samples for low parasitaemia from febrile patients without microscopically
detectable Plasmodium infections in a rural malaria-endemic setting.
Methods: Blood samples (n = 197) were collected in two islands of Lake Victoria, Kenya, from febrile patients
without Plasmodium detectable by microscopy or RDTs. 18S rRNA gene sequences were amplified from extracted
DNA by nPCR-HRM, nPCR, and dPCR-HRM to detect and differentiate Plasmodium parasites. The limits of detection
(LoD) were compared using serial dilutions of the WHO International Standard for P. falciparum DNA. Data on
administration of anti-malarials were collected to estimate prescription of anti-malarial drugs to patients with and
without low parasitaemia Plasmodium infections.
Results: The coupled nPCR-HRM assay detected Plasmodium parasites with greater sensitivity (LoD = 236 parasites/mL)
than either nPCR (LoD = 4,700 parasites/mL) or dPCR-HRM (LoD = 1,490 parasites/mL). Moreover, nPCR-HRM
detected and differentiated low-parasitaemia infections in significantly greater proportions of patients than did
either nPCR or dPCR-HRM (p-value <0.001). Among these low-parasitaemia infections, 67.7% of patients were treated
with anti-malarials, whereas 81.5% of patients not infected with Plasmodium parasites were treated with anti-malarials.
Conclusions: The enhanced sensitivity of nPCR-HRM demonstrates limitations of differential febrile illness diagnostics
in rural malaria endemic settings that confound epidemiological estimates of malaria, and lead to inadvertent
misadministration of anti-malarial drugs. This is the first study that employs low-parasitaemia Plasmodium diagnostics to
quantify the prescription of anti-malarial drugs to both non-malaria febrile patients and patients with low-parasitaemia
Plasmodium infections. nPCR-HRM enhances low-parasitaemia malaria diagnosis and can potentially surmount the
deficiencies of microscopy and RDT-based results in determining low-parasitaemia Plasmodium infection rates for
evaluating malaria elimination efforts. The findings highlight the need for improved differential diagnostics of febrile
illness in remote malaria endemic regions.
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The World Health Organization (WHO) estimates that
despite recent reductions in malaria incidence, malaria
contributed to the morbidity and mortality of about 166
million and 564,000 people, respectively, in sub-Saharan
Africa (SSA) in 2012 [1]. However, other epidemiological
estimates nearly double these figures [2]. It is unclear
how ‘presumptive diagnosis’ has influenced these statis-
tics [3], since patients presenting with febrile illnesses
with undetected parasitaemia by microscopy or rapid
diagnostic tests (RDTs) are inadvertently integrated into
the statistics, confounding prevalence measures of mal-
aria in the process [4-6].
Appropriate diagnosis is not only important for ensuring
prudent use of anti-malarial medications, and facilitating
correct prognosis based on appropriate differential diagno-
sis [1,7,8], but also for tracking malaria elimination efforts
[9-11]. Conventional microscopy [12] and RDT-based mal-
aria diagnostics [13] used in malaria endemic regions of
Africa have relatively low sensitivity and specificity in the
detection of low-parasitaemia infections [14,15]. Although
the limits of detection (LoD) of parasitaemia by micros-
copy (100 parasites/μL or higher depending on technical
skills) [16,17] and RDT (50–400 parasites/μL) [18] may be
well below the estimated parasite density threshold (3,500
parasites/μL) for initiation of febrile episodes [19], many
clinicians in areas of high malaria endemicity are com-
pelled to heuristically prescribe anti-malarials on the basis
of clinical symptoms alone [6,7,20-22]. Such diagnostic and
anti-malarial prescription practices in the absence of
malaria positive microscopy and/or RDT results [6-8]
may cause overlooking potentially severe non-malarial
febrile illnesses that may coexist in malaria endemic
tropical regions, such as bacterial, mycobacterial, fun-
gal, and arthropod-borne viral infections [20,11,23,24].
Indeed, even reliance on RDTs, which may also detect
sub-clinical Plasmodium parasitaemia, has been impli-
cated in undermining considerations of such differential
diagnoses [10].
While low-parasitaemia Plasmodium diagnostics may be
inappropriate for attributing febrile symptoms to malaria,
effective malaria elimination efforts must be able to iden-
tify sub-clinical, low-parasitaemia Plasmodium infections
that contribute to the infectious reservoir [12]. Molecular
techniques are generally superior to antigen-detection tests
and microscopy for detecting pathogens in biological sam-
ples [12,13,25,26]. Specifically, techniques such as nested
Polymerase chain reaction (nPCR) can enhance the sensi-
tivity of detecting low-parasitaemia Plasmodium infections
by increasing the total number of PCR cycles and by dilut-
ing the inhibitors present in the initial amplification reac-
tion [27]. Similarly, direct PCR with high resolution
melting (dPCR-HRM) analysis can distinguish between dif-
ferent Plasmodium species in a sample [28] and can henceprovide better information on the relative abundance and
composition of Plasmodium species in a study area.
This paper describes a novel molecular diagnostic
technique that combines nested PCR with HRM analysis
(nPCR-HRM) to detect and differentiate low-parasitaemia
Plasmodium infections. The sensitivity of the novel coupled
nPCR-HRM approach was compared to the performance
of separate and independent implementations of nPCR [27]
and dPCR-HRM [28] assays. The novel technique was fur-
ther applied to quantify misadministration of anti-malarial
drugs among patients presenting febrile symptoms without
Plasmodium infections detectable by microscopy or RDTs
in rural clinics on Rusinga and Mfangano Islands of Lake
Victoria in Kenya.Methods
The study was approved by the National Ethical Review
Board located at the Kenya Medical Research Institute,
KEMRI (Approval Ref: Non-SSC Protocol #310). Project
staff explained the study to the participants in the local
language and provided participants with study informa-
tion. Written informed consent was obtained from all pa-
tients sampled with febrile illness. Adults accompanying
patients between 12 and 17 years old consented on behalf
of the patients.Study sites
The study was conducted on the Lake Victoria islands of
Mfangano (at Sena Health Centre, 0°28'24.10"S/34°
4'2.54"E) and Rusinga (at Tom Mboya Health Centre, 0°
24'0.66"S/34°9'50.52"E) located in western Kenya. Both
islands have a population of between 20,000 and 30,000
people, and are in the Mbita constituency of Homa Bay
County, a malaria endemic region in western Kenya.
This region has recorded malaria prevalence as high as
50% between 2001 and 2004 [29]. Malaria transmission
fluctuates with seasons, but is sustained throughout the
year in the two islands. Anopheles gambiae, Anopheles
arabiensis, and Anopheles funestus are the primary vec-
tors of malaria [30] with Plasmodium falciparum as the
most prevalent malaria parasite [31]. Rusinga Island is
connected to the mainland via a 250-metre causeway
constructed in the early 1980s through rock and earth
filling. Mfangano Island is more isolated, located ap-
proximately 16 Km from the mainland. Both Sena and
Tom Mboya Health Centres rely heavily on microscopy
for malaria diagnostics, and use RDT’s inconsistently, as
available. The area typically experiences long and short
rainy seasons that are accompanied with an upsurge of
malaria infections. The long rains extend from March to
May and the short rains between August and December.
Temperatures range from 17°C to 34°C with annual
rainfall ranging between 700 mm to 1,200 mm [32].
Kipanga et al. Malaria Journal 2014, 13:429 Page 3 of 8
http://www.malariajournal.com/content/13/1/429Human blood sampling
Blood sampled from patients visiting the two health cen-
tres presenting with febrile symptoms (fever above 37.5°C,
headache, joint pains, diarrhoea, cough, abdominal pain,
constipation, nausea) were screened for the presence of
Plasmodium parasites by microscopy (thick blood smear)
and RDT (CareStart™ Malaria HRP2(Pf)). Patients who
provided samples with detectable Plasmodium parasites
using these approaches were treated for malaria, allowed
to go home and were excluded from this study. Blood
(3 mL) from consecutive RDT and smear-negative febrile
patients was drawn from consenting patients (12 years
and above). All patients that had taken anti-malarial drugs
within the preceding two weeks were excluded from the
study. Blood samples from patients were collected using
heparinized vacutainer collection tubes (MacMed Health-
care), aliquoted into three separate cryovials, and immedi-
ately stored in liquid nitrogen shippers. Trained hospital
personnel also filled out structured questionnaires pertain-
ing to demographic and clinical data of patients. To
minimize selection bias, only two patients per week from
each clinic were included in the study. Filled shippers and
questionnaires were transported back to the laboratory for
analysis. To protect patient anonymity, all blood samples
and questionnaires were labelled with barcode identifiers.
All samples were collected between May 2012 and
October 2013, facilitated by staff in the Division of Disease
Surveillance and Response (DDSR) of the Kenyan Ministry
of Public Health and Sanitation.
Extraction of total DNA from blood
Total DNA in blood samples were extracted by methods
of Kawasaki [33] with minor modifications. Briefly,
50 μL of blood samples were separately transferred from
cryovials to respective 1.5 mL eppendorf tubes contain-
ing 0.5 mL of Tris-EDTA (TE) buffer (10 mM Tris–HCl,
1 mM EDTA; pH 8.0). The samples were vortexed for
ten seconds and centrifuged for five minutes at 13,000
relative centrifugal force (rcf ) at 4°C. The resultant su-
pernatants were discarded and the pellets were washed
three times by re-suspending in the TE buffer, vortexing
for ten seconds, and centrifuging for five minutes. The
final pellets were re-suspended in 100 μL of proteinase
K buffer (1.5 mM MgCl2, 50 mM KCl, 0.5% Tween 20,
100 μg/mL proteinase K and 10 mM Tris–HCl; pH 8.3),
vortexed for ten seconds, and incubated at 55°C for an
hour. The extracted DNA was incubated at 95°C for
10 minutes to inactivate the proteinase K, and then
stored at −20°C until required.
Detection of Plasmodium parasites by nPCR-HRM
The extracted DNA was amplified using nested PCR,
targeting 18S rRNA genes in Plasmodium DNA. For the
primary amplification step, forward (PL-1459-F: CTGGTT AAT TCC GAT AAC), and reverse (PL-1706-R:
TAA ACT TCC TTG TGT TAG AC) primers were de-
signed using Primer3 software [34]. The second pair of
primers used for the nested amplification reaction were
PL-1473-Forward (3’-TAA CGA ACG AGA TCT TAA-
5’) and PL-1679-Reverse (3’-GTT CCT CTA AGA AGC
TTT-5’) primers targeting a 204–270 base pair fragment
(depending on the Plasmodium species) of a poly-
morphic region in the 18S rRNA gene [28]. Ten-fold di-
lutions of the primary PCR products were used as
templates for the nested reactions. Each of the two amp-
lification reactions were carried out in 10 μL final reac-
tion volumes consisting of 1 μL DNA template, 2 μL
Hot Firepol® HRM mix kit (Solis BioDyne, Estonia),
0.5 μL of 0.5 μM of both primers and 6 μL nuclease free
PCR water. The touchdown PCR thermal conditions
consisted of an initial denaturation at 95°C for 5 minutes,
45 cycles of denaturation at 94°C for 20 seconds, de-
creasing annealing temperatures from 65°C to 50°C for
25 seconds (cycles 1–5), 50°C for 40 seconds (cycles
6–10), 50°C for 50 seconds (cycles 11–45), and extension
at 72°C for 30 seconds. A final extension of 72°C for
3 minutes was included before HRM analysis. Upon
completion, the nested PCR process was transitioned
into the melting phase (HRM) in the same closed tube
system yielding distinct melting profiles in a Rotor-Gene
Q® machine (QIAGEN, Germany). The set of conditions
for HRM included 0.2°C incremental temperature in-
creases from 75°C to 90°C, with fluorescence acquisition
at the end of each 2 second temperature increment.
DNA extracts from P. falciparum infected blood and
deionized water were used as positive and negative
controls, respectively. Products that produced curves
distinct from the P. falciparum positive control were se-
quenced by Macrogen (Seoul, Korea) and aligned with ref-
erence sequences for Plasmodium malariae [GenBank:
AB489193] and Plasmodium ovale [GenBank:AJ001527]
using Geneious 6.1.6 software [35]. Protocols for nPCR
[27] and dPCR-HRM [28] were also separately used on all
samples for comparison purposes.
Validation of nPCR-HRM sensitivity in comparison to
established nPCR and dPCR-HRM protocols
To compare the detection limits of the three assays, we
used the WHO International Standard for P. falciparum
DNA, a standardized freeze-dried preparation of P. falcip-
arum infected whole blood obtained from the National In-
stitute for Biological Standards and Control (NIBSC;
Hertfordshire, UK). Following NIBC recommendations, the
lyophilized material was suspended in 500 μL of sterile,
nuclease-free water to a final concentration of 1 × 109 IU/
mL, estimated to be 469,920 parasites/μL [36]. To establish
and compare each assay’s LoD, we serially diluted the sus-
pension in fresh uninfected whole blood. The sensitivity of
Figure 1 Comparison of molecular techniques for low-
parasitaemia Plasmodium detection among samples from
microscopically negative febrile patients. Total Plasmodium and
P. falciparum prevalence among patient samples as determined by
nPCR-HRM, dPCR-HRM, and nPCR. Error bars indicate the upper limit
of the 95% CI.
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single-log (ten-fold) serial dilutions for the first four dilu-
tion points and four replicate extractions of each of the fol-
lowing eight half-log (3.16-fold) serial dilutions. The lowest
concentration of DNA that tested positive in all replicates
of a particular assay was set as the LoD. To narrow down
the LoD further, additional tests were performed on half-
log and two-fold dilutions of the lowest concentration that
could be consistently detected among the original serial di-
lution series. To assess the rate of possible false positives
due to cross-contamination during the nested amplification
step of nPCR-HRM, 20 negative controls, including eight
extraction negative controls, were distributed in every
third position, such that each DNA standard serial di-
lution amplification was adjacent to a negative control
reaction.
Statistical methods
McNemar’s Chi-Square tests were used to compare the
sensitivity of nPCR-HRM to nPCR and dPCR-HRM in de-
tecting parasitaemia. Continuous/Gaussian data were com-
pared using t-tests while Cohen’s Kappa was calculated to
compare the agreement between the results obtained using
the different methods. All statistical inferences were drawn
on two-tailed distributions with α = 0.05. The data were
analysed using R 3.0.1 software [37].
Results
Characteristics of study subjects
While 5,672 and 1,412 patients tested positive for malaria
at Sena and Tom Mboya Health Centres, respectively,
during the study period, 197 subjects with undiagnosed fe-
brile illness were enrolled into the study. Subjects were be-
tween 12 and 70 years of age with a mean and median age
of 31.9 and 28.0 years, respectively. There were 114 fe-
males and 81 males, with the gender of two individuals
not reported. About 53.3% (n = 105) of the subjects were
recruited from Sena Health Centre between Oct 15, 2012
and Oct 15, 2013 and the rest (n = 92) from Tom Mboya
Health Centre between May 28, 2012 and Feb 18, 2013.
Although 7,553 and 2,378 patients tested negative for mal-
aria at Sena and Tom Mboya Health Centres, respectively,
only two smear/RDT-negative patients from each clinic
were included in the study every week to minimize time-
based selection bias. The mean age for the subjects
recruited from Sena Health Centre was 29.1 years old.
This population was significantly younger than that re-
cruited from Tom Mboya Health Centre, which averaged
35.4 years old (t = 3.3, df = 147.53, p = 0.001).
Sensitivity comparison of the three techniques using serial
dilutions of the WHO Plasmodium DNA International Standard
The LoD of the coupled nPCR-HRM technique was 236
parasites/mL, whereas the LODs of dPCR-HRM andnPCR were 1,490 parasites/mL and 4,700 parasites/mL,
respectively.
Malaria and P. falciparum prevalence as generated by the
three techniques
Prevalence estimates of Plasmodium parasitaemia ge-
nerated by our nPCR-HRM technique relative to those
generated through nPCR or dPCR-HRM techniques are
summarized in Figure 1. Results obtained by nPCR-HRM
were in substantial agreement with those obtained by
dPCR-HRM (Kappa = 0.699; 95% CI, 0.589-0.809) and fair
agreement with those obtained by nPCR (Kappa = 0.395;
95% CI, 0.266-0.524). Nonetheless, our novel nPCR-HRM
method detected significantly more cases of overall
Plasmodium infections than did either dPCR-HRM (χ1
2 =
21.04, p <0.001) or nPCR (χ1
2 = 40.02, p <0.001). More spe-
cifically, nPCR-HRM also detected significantly more cases
of P. falciparum infections than did either dPCR-HRM
(χ1
2 = 22.04, p <0.001) or nPCR (χ1
2 = 34.02, p <0.001).
Based on nPCR-HRM analyses, 62 (31.5%; 95% CI, 25.0-
38.0) of the 197 subjects enrolled in the study had Plasmo-
dium parasites in their samples, of which 53 (26.9%; 95%
CI, 20.7-33.1) had P. falciparum parasites. While P. falcip-
arum prevalence did not significantly differ between the
two sampling sites during the study period (p = 0.137), the
overall Plasmodium spp. prevalence was greater in sam-
ples collected at Tom Mboya Health Centre than those
collected at Sena Health Centre (p = 0.013). Samples with
Plasmodium collected at Tom Mboya Health Centre also
had higher Plasmodium species diversity than those col-
lected at Sena Health Centre. Samples collected at Tom
Mboya Health Centre included 26 (72.2%) P. falciparum
only infections, five (13.9%) P. malariae only infections,
two (5.6%) P. ovale only infections, two (5.6%) double in-
fections of P. falciparum and P. ovale, and one (2.8%)
Figure 2 Representative Plasmodium HRM profiles from a
subset of the study samples. Distinct melting profiles, represented
by change in fluorescence units with increasing temperatures (df/dt)
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Figure 3 Anti-malarial treatment of febrile patients with and
without low parasitaemia Plasmodium infections identified by
nPCR-HRM. Numbers of patients treated or not treated with
anti-malarial drugs in Sena and Tom Mboya Health Centres.
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Samples collected at Sena Health Centre had only two P.
ovale infections with the remaining 24 infections being P.
falciparum. The unique HRM profiles of the three
Plasmodium parasites are represented in Figure 2. Based
on dPCR-HRM, only 39 (19.8%; 95% CI, 14.2-25.4) of the
patient samples had detectable Plasmodium parasites,
among which 27 (13.7%; 95% CI, 8.9-18.5) were P. falcip-
arum infections. nPCR revealed malaria parasites in only
20 (10.2%; 95% CI, 5.9-14.4) of the samples, among which
15 (7.6%; 95% CI, 3.9-11.3) were P. falciparum infections.
No mixed infections were detected by either nPCR or
dPCR-HRM. To verify that the nested amplification ap-
proaches did not yield false positives due to cross-
contamination, these assays were repeated with the same
samples in three successive runs, all of which produced
identical results for the individual samples.
Anti-malarial drug prescription patterns
Among the 197 patients presenting with febrile illness
enrolled in this study, 152 (77.2%) were treated with
anti-malarial drugs. While 42 (67.7%) of the 62 patients
with detectable Plasmodium parasites were treated with
anti-malarial drugs, 110 (81.5%) of the 135 patients with-
out detectable Plasmodium parasites were incorrectly
treated with anti-malarial drugs. However, these patterns
differed between the two Health Centres, as represented
in Figure 3. While in Tom Mboya Health Centre, only
16 (44.4%) of the 36 patients with detectable Plasmo-
dium parasites were treated with anti-malarial drugs, all
26 malaria patients with detectable parasites at Sena
Health Centre were treated with anti-malarials. Yet,
among the patients that did not have Plasmodiuminfection, more than half were treated with anti-malarial
drugs at both Tom Mboya (32 out of 56, 57.1%) and
Sena Health Centres (78 out of 79, 98.7%).
Discussion
By combining the high sensitivity of nested PCR with
real-time species differentiating HRM analysis, the
reporting of Plasmodium infection prevalence that in-
cludes low-parasitaemia infections can be synergistically
enhanced to improve size estimates of its infectious hu-
man reservoir in regions where malaria elimination ef-
forts are being scaled up. Indeed, nPCR-HRM was able
to detect P. falciparum at orders of magnitude lower
concentrations than either nPCR or dPCR-HRM. The
LoD of the coupled nPCR-HRM assay (236 parasites/
mL) is however in the same range as TaqMan Probe as-
says validated using the same P. falciparum DNA stand-
ard (313 parasites/mL) [36]. Out of the 62 patient
samples in which Plasmodium parasites were detected
by the novel nPCR-HRM technique, the well-established
nPCR [27] and dPCR-HRM [28] molecular techniques
detected Plasmodium parasites in only 20 and 39 sam-
ples, respectively. The same is evident for P. falciparum,
where nPCR-HRM identified 26.9% prevalence among
microscopically negative febrile illness patients, while
nPCR and dPCR-HRM identified only 10.2% and 13.7%
prevalence, respectively. These results are consistent
with the lower sensitivity of nPCR previously reported in
comparison to dPCR-HRM [38], yet further demonstrate
that nPCR-HRM is significantly more sensitive and spe-
cific than either nPCR or dPCR-HRM, and was also the
only method able to detect double and triple infections
with distinct Plasmodium parasites.
Although other novel molecular methods for Plasmo-
dium detection have been reported recently, they either
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on clinical specimen [39] or were limited in ability to dif-
ferentiate Plasmodium species [25,36]. Due to these limi-
tations in detecting and differentiating low-parasitaemia
Plasmodium infections, no previous studies have assessed
drug administration among subjects with malaria parasit-
aemia below the detection limits of standard microscopy
and RDT.
The lack of diagnostic tools sufficiently sensitive to de-
tect low Plasmodium parasitaemia in rural clinics in mal-
aria endemic regions of SSA, and that can differentially
diagnose other non-malaria febrile illnesses, including bac-
terial, mycobacterial, fungal, and arboviral infections, is a
big challenge [12,20-24]. While limited training of labora-
tory technicians has been suggested as a cause of poor
malaria diagnoses [40], clinicians are left with little option,
as a result of diagnostic limitations in rural clinics, but to
treat patients with anti-malarials and antibiotics based on
clinical symptoms [6,7,20-22].
Febrile illness misdiagnosis can be significant in malaria
endemic settings, resulting in a myriad of downstream is-
sues including improper treatment, chronic suffering of pa-
tients as the underlying cause of illness remains unknown,
and drug wastage [7]. Moreover, poor malaria diagnostics
can undermine the diagnosis of non-malarial febrile ill-
nesses [10,23,24]. Due to the limitations of microscopy and
RDTs in detecting low-parasitaemia malaria [14,15] and
clinical heuristic treatment practices [6,7,20-22], 197 febrile
patients from both study sites were diagnosed as not hav-
ing malaria, but were still given different medications on
the basis of clinical signs. In endemic regions with high
transmission intensity, such presumptive fever manage-
ment may be justifiable, as test-based management may
not be safe or cost effective [10]. Because clinicians are lim-
ited to heuristic methods of clinical diagnoses in such
cases, treatment patterns are likely to differ between clinics
and clinicians. Indeed, while all low Plasmodium parasit-
aemia cases at Sena Health Centre were treated with anti-
malarial drugs, only 44.4% of low-parasitaemia patients at
Tom Mboya Health Centre were treated with anti-malarial
drugs. However, in both Health Centres, the majority of
anti-malarial drugs were prescribed to patients in whom
we did not detect Plasmodium parasitaemia.
The discrepant prescribing patterns between the two
study sites may be due to the over three times greater
numbers of patients with microscopically positive malaria
observed at Sena Health Centre than at Tom Mboya
Health Centre during the respective sampling periods.
Accessibility to other health facilities may also have influ-
enced prescribing practices. Compared to Tom Mboya
Health Centre on Rusinga Island, Sena Health Centre on
Mfangano Island is more isolated from the mainland
where patients access other nearby and specialized health
centres that they may be referred to for assessment ofdifferential diagnoses. Due to the relatively limited accessi-
bility to such referral clinics for patients on Mfangano
Island, clinicians may have had a stronger tendency to pre-
scribe the more readily available anti-malarials at Sena
Health Centre.
Individuals with extremely low-parasitaemia Plasmodium
infection are likely to have endemic stability to malaria
infection and may be able to tolerate a low degree of para-
sitaemia with absence of clinical disease [19]. Therefore,
anti-malarial drugs do not treat febrile illness patients with
sub-microscopic Plasmodium infections for the underlying
differential diagnosis of their febrile symptoms [10]. None-
theless, treatment of patients with sub-microscopic Plas-
modium infection, may contribute to integrated malaria
elimination/control efforts by reducing the size of the infec-
tious reservoir within communities [9-11].
This study demonstrates how improper febrile illness
diagnoses confound prevalence estimates of Plasmodium
infections and other differential diagnoses. Some non-
malaria febrile patients are diagnosed and treated for
malaria based on their clinical symptoms, and may be
inadvertently integrated into epidemiological statistics
[3-6], while some low-parasitaemia Plasmodium infec-
tions go unrecognized [2]. As a result, malaria burden
and infection estimates suffer from unknown large mar-
gins of error [4]. The complementary use of sensitive
and specific molecular based methods informs size esti-
mates of the potential infectious reservoir of malaria in
endemic regions, while also providing estimates of undif-
ferentiated febrile illness burden.
Improved understanding of Plasmodium infection rates
will translate into the development of better rural malaria
diagnostics and treatments, ultimately reducing gameto-
cyte incidence rates in asymptomatic populations with
low-parasitaemia malaria [12]. While individuals with sub-
microscopic parasitaemia have significantly lower Plasmo-
dium transmission rates to mosquito vectors [41,42], they
may still constitute a considerable proportion of the hu-
man infectious reservoir [12,42,43], a phenomenon that
probably prevails among individuals with endemic stability
to malaria infection in the endemic study sites. Therefore,
more accurate parasite-detection based diagnosis and
treatment may reduce malaria transmission [42]. Low-
parasitaemia malaria can result in acute febrile illness [5]
and individuals that may have low-parasitaemia in the per-
ipheral blood may still require anti-malarial treatment due
to higher parasite loads that can still be sequestered in ca-
pillaries [44]. In contrast, acute febrile illnesses have many
aetiologies ranging from bacterial, fungal and mycobacter-
ial infections to arboviral infections [24]. These unknowns
complicate appropriate febrile illness diagnosis and treat-
ment. Clear guidelines and policies on the management of
non-malaria acute febrile illnesses are required urgently,
particularly in malaria endemic regions.
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detection and species differentiation is a valuable mo-
lecular tool that can be used to complement microscopy
and RDT and enhance understanding of specific Plasmo-
dium infection rates. While sensitive and specific, nPCR-
HRM was not designed as a diagnostic tool for health
clinics, as it requires real-time PCR infrastructure, spe-
cialized training to avoid the cross-contamination risks
associated with nested PCR assays, and more man power
in comparison to RDTs. Recent developments in both
loop-mediated isothermal amplification (LAMP) [25]
and isothermal lateral flow-recombinant polymerase
amplification (LF-RPA) [26] assays show promise as true
point-of-care tests with high specificity and sensitivity
for detecting low-parasitaemia Plasmodium infections.
Nonetheless, nPCR-HRM can be employed for monitor-
ing low-parasitaemia infection rates within malaria en-
demic regions to assess the progress of regional malaria
elimination efforts.
Conclusions
This is the first study that employs low-parasitaemia
Plasmodium diagnostics to quantify both the over-
prescription of anti-malarial drugs in non-malaria febrile
patients and under-prescription of anti-malarial drugs in
low-parasitaemia malaria patients. While patient febrile ill-
ness symptoms cannot be attributed to any of the sub-
microscopic Plasmodium infections identified in this
study, consistent anti-malarial treatment limited to such
cases should contribute to regional malaria elimination ef-
forts [9-11]. Other recent cohort studies have contrasted
presumptive clinical diagnoses and anti-malarial drug
treatments with malaria parasitaemia detectable by mi-
croscopy [21,23,24], as microscopy [8], alongside RDTs
[5], is the mainstay of present malaria diagnostic practices
in most malaria endemic regions of Africa. In a low trans-
mission area clinical cohort study in Tanzania, Reyburn
and colleagues found that 38% of suspected malaria pa-
tients were treated for malaria without further testing and
48% of microscopically malaria negative febrile patients
were presumptively treated with anti-malarial drugs [21].
More recently, Crump and colleagues showed that only
2.7% of patients diagnosed with malaria in two hospitals in
northern Tanzania were actually malaria positive as de-
termined by microscopy [24]. Considering Plasmodium
infection prevalence, we further demonstrate the inad-
equacy of rural diagnostics in detecting low-parasitaemia
infections.
While patients with undiagnosed and untreated low-
parasitaemia Plasmodium infections may not suffer from
acute febrile illness as a result of malaria, they may con-
tribute to a significant proportion of the infectious reser-
voir during their asymptomatic state. Conversely, the
lack of diagnostics and treatment for unrecognizeddifferential febrile illness diagnoses may have severe health
implications that cannot be addressed properly. Epide-
miological estimates need to take into account the consid-
erable proportions of asymptomatic low-parasitaemia
Plasmodium infections that contribute to the infectious
reservoir, while also considering the health impacts of
unrecognized differential diagnoses of febrile illness in
malaria endemic regions.
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